IndraLab

Statements

USP37 inhibits cisplatin. 6 / 6
| 2 4
reach
"Additionally, USP37 knockdown enhanced the sensitivity of breast cancer cells to cisplatin in vitro and in vivo."
30482232
eidos
"Additionally , USP37 knockdown enhanced the sensitivity of breast cancer cells to cisplatin in vitro and in vivo ."
30482232
reach
"Additionally, USP37 knockdown inhibited tumorigenicity and increased anticancer effect of cisplatin in vivo."
30482232
reach
"USP37 can regulate the stemness, cell invasion and EMT via Hh pathway, and decreased USP37 confers sensitivity to cisplatin in breast cancer cells."
30482232
reach
"USP37 knockdown inhibits tumorigenicity and increases sensitivity to cisplatin in vivo."
30482232
eidos
"These results indicated that USP37 downregulation attenuates breast cancer progression and enhances sensitivity to cisplatin in vivo ."
30482232